Toolkit/Rhodamine 123 mitochondrial transmembrane potential assay

Rhodamine 123 mitochondrial transmembrane potential assay

Assay Method·Research·Since 1992

Also known as: rhodamine 123 retention assay

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Mitochondrial transmembrane potential, assayed by retention of rhodamine 123 was preserved in apoptotic but not necrotic cells.

Usefulness & Problems

Why this is useful

This assay uses rhodamine 123 retention as a flow-cytometric readout of mitochondrial transmembrane potential.; assaying mitochondrial transmembrane potential; distinguishing apoptotic from necrotic cells

Source:

This assay uses rhodamine 123 retention as a flow-cytometric readout of mitochondrial transmembrane potential.

Source:

assaying mitochondrial transmembrane potential

Source:

distinguishing apoptotic from necrotic cells

Problem solved

It helps distinguish apoptotic from necrotic cells by monitoring whether mitochondrial transmembrane potential is preserved.; provides an organelle-function readout that differs between apoptotic and necrotic cells

Source:

It helps distinguish apoptotic from necrotic cells by monitoring whether mitochondrial transmembrane potential is preserved.

Source:

provides an organelle-function readout that differs between apoptotic and necrotic cells

Problem links

provides an organelle-function readout that differs between apoptotic and necrotic cells

Literature

It helps distinguish apoptotic from necrotic cells by monitoring whether mitochondrial transmembrane potential is preserved.

Source:

It helps distinguish apoptotic from necrotic cells by monitoring whether mitochondrial transmembrane potential is preserved.

Published Workflows

Objective: Differentiate apoptosis from necrosis and identify early apoptotic changes and cell-cycle phase specificity using multiparameter flow-cytometric readouts.

Why it works: The review describes combining orthogonal cellular features so that apoptosis and necrosis can be separated by differences in DNA behavior, membrane integrity, organelle function, and scatter properties rather than relying on a single marker.

endonuclease-associated low molecular weight DNA extractionloss or preservation of plasma membrane integritypreservation or loss of mitochondrial transmembrane potentialpreservation or loss of ATP-dependent lysosomal proton pumpingDNA strand-break formationflow cytometrymultiparameter fluorescent stainingbivariate analysis

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Target processes

No target processes tagged yet.

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor

It requires rhodamine 123 and a fluorescence-capable flow cytometer.; requires rhodamine 123 staining; depends on flow-cytometric retention measurement

The abstract does not indicate that it alone resolves early versus late apoptotic stages or cell-cycle specificity.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1review summarysupports1992Source 1needs review

Acridine orange staining at low pH provides a sensitive and early assay to discriminate live, apoptotic, and necrotic cells and to evaluate cell-cycle phase specificity.

Claim 2review summarysupports1992Source 1needs review

Propidium iodide exclusion combined with Hoechst 33342 staining is described as an excellent probe for distinguishing live, necrotic, early-apoptotic, and late-apoptotic cells.

Claim 3review summarysupports1992Source 1needs review

Rhodamine 123 retention indicates that mitochondrial transmembrane potential is preserved in apoptotic but not necrotic cells.

Claim 4review summarysupports1992Source 1needs review

Supravital acridine orange uptake indicates that ATP-dependent lysosomal proton pump function is preserved in apoptotic but not necrotic cells.

Approval Evidence

1 source1 linked approval claimfirst-pass slug rhodamine-123-mitochondrial-transmembrane-potential-assay
Mitochondrial transmembrane potential, assayed by retention of rhodamine 123 was preserved in apoptotic but not necrotic cells.

Source:

review summarysupports

Rhodamine 123 retention indicates that mitochondrial transmembrane potential is preserved in apoptotic but not necrotic cells.

Source:

Comparisons

Source-stated alternatives

The review contrasts this with PI/Hoechst membrane-integrity probing, acridine orange assays, DNA content measurements, and nick translation for DNA strand breaks.

Source:

The review contrasts this with PI/Hoechst membrane-integrity probing, acridine orange assays, DNA content measurements, and nick translation for DNA strand breaks.

Source-backed strengths

captures preservation of mitochondrial transmembrane potential in apoptotic but not necrotic cells

Source:

captures preservation of mitochondrial transmembrane potential in apoptotic but not necrotic cells

Compared with assays

The review contrasts this with PI/Hoechst membrane-integrity probing, acridine orange assays, DNA content measurements, and nick translation for DNA strand breaks.

Shared frame: source-stated alternative in extracted literature

Strengths here: captures preservation of mitochondrial transmembrane potential in apoptotic but not necrotic cells.

Source:

The review contrasts this with PI/Hoechst membrane-integrity probing, acridine orange assays, DNA content measurements, and nick translation for DNA strand breaks.

Ranked Citations

  1. 1.
    StructuralSource 1Cytometry1992Claim 1Claim 2Claim 3

    Seeded from load plan for claim c3. Extracted from this source document.